{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:11:09Z","timestamp":1790835069207,"version":"4.1.0"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7806","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T22:11:35Z","timestamp":1494799895000},"page":"1207-1212","source":"Crossref","is-referenced-by-count":4,"title":["Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation"],"prefix":"10.2169","volume":"56","author":[{"given":"Satoko","family":"Oka","sequence":"first","affiliation":[{"name":"Division of Hematology, Japanese Red Cross Society Wakayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Pathology, Japanese Red Cross Society Wakayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Nohgawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Japanese Red Cross Society Wakayama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80: 355-377, 2001."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12: 530-534, 2003.","DOI":"10.1191\/0961203303lu394oa"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Miesbach W, Asherson RA, Cervera R, et al. The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev 6: 94-97, 2006.","DOI":"10.1016\/j.autrev.2006.06.012"},{"key":"4","unstructured":"4. Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol 33: 355-357, 2006."},{"key":"5","unstructured":"5. Marmont AM. New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation. Annu Rev Med 51: 115-134, 2000."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miesbach W. Malignancies and catastrophic anti-phospholipid syndrome. Clin Rev Allergy Immunol 36: 91-97, 2009.","DOI":"10.1007\/s12016-008-8101-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2013: 675-680, 2013.","DOI":"10.1182\/asheducation-2013.1.675"},{"key":"8","unstructured":"8. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46: 1019-1027, 2002."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Olalla JI, Ort\u00edn M, Hermida G, et al. Disappearance of lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 23: 83-85, 1999.","DOI":"10.1038\/sj.bmt.1701516"},{"key":"10","unstructured":"10. Owaidah TM, Maghrabi K, Elkarouri MA, Al Mohareeb F, Al Harthi A, Al Zahrani H. Successful treatment of a case of catastrophic antiphospholipid syndrome with autologous BMT: case report and review of literature. Bone Marrow Transplant 46: 597-600, 2011."},{"key":"11","unstructured":"11. Asherson RA, Espinosa G, Menahem S, et al. Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum 37: 366-372, 2008."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Eisenberg R, Albert D. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol 2: 20-27, 2006.","DOI":"10.1038\/ncprheum0042"},{"key":"13","unstructured":"13. Maeshima AM, Taniguchi H, Toyoda K, et al. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. Br J Haematol 174: 923-931, 2016."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Meyer AH, Stroux A, Lerch K, et al. Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma. Ann Oncol 25: 210-215, 2014.","DOI":"10.1093\/annonc\/mdt507"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Brown JR, Gaudet G, Friedberg JW, et al. Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma. Leuk Lymphoma 45: 315-320, 2004.","DOI":"10.1080\/10428190310001593157"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Li L, Bierman P, Vose J, Loberiza F, Armitage JO, Bociek RG. High-dose therapy\/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk 11: 253-256, 2011.","DOI":"10.1016\/j.clml.2011.03.011"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7806\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:39:28Z","timestamp":1569343168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7806\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7806","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}